newsfilter
← Latest News
GlobeNewswire·

Eloxx Pharmaceuticals Announces Reverse Stock Split Effective

WATERTOWN, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (the "Company") (NASDAQ:ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced that its Board of